Study to Compare Initial Dosing Parameters of Zemplar in Stage V Chronic Kidney Disease Subjects on Hemodialysis

PHASE4CompletedINTERVENTIONAL
Enrollment

201

Participants

Timeline

Start Date

June 30, 2003

Conditions
Kidney Failure, Chronic
Interventions
DRUG

Zemplar

Trial Locations (19)

11526

Errikos Dynan Hospital, Ambelokipi

11527

"General Hospital of Athens, G.Gennimatas", Cholargós

11528

Blue Cross Clinic, Athens

Evgenidio Clinic, Athens

15126

"General Hospital of Attica Sismanoglio", Marousi

15127

"General Hospital of Melissia Amalia Fleming", Melíssia

16673

General Hospital of Voula Askilpieion, Voula

68100

General University Hospital of Alexandroupolis, Dragana

152 00

"Hygeia Diagnosis and Therapy Center", Marousi

Unknown

General Hospital of Heraklion, Voutes, Heraklion

General Hospital of Veria, Papagou Area

"Regional General Hospital of Athens Korgialeneio-Benakeio", Athens

"General Hospital of Nikea Agios Panteleimon", Nikea, Piraeus 18454,

"General Hospital of Thessaloniki Ahepa", Thessaloniki

"General Hospital of Thessaloniki Hippokrateion", Thessaloniki

"General Hospital of Thessaloniki Papageorgiou", Thessaloniki

570 10

"General Hospital Thessaloniki Papanikolaou", Eksochi

450 01

"Regional General Hospital of Ioannina Hatzikosta", Ioannina

455 00

General University Hospital Ioannina, Ioannina

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Abbott

INDUSTRY

NCT00091481 - Study to Compare Initial Dosing Parameters of Zemplar in Stage V Chronic Kidney Disease Subjects on Hemodialysis | Biotech Hunter | Biotech Hunter